Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 34.53
+0.38 (1.11%)
Apr 8, 2026, 3:04 PM CST
SHE:000513 Revenue
In the year 2025, Livzon Pharmaceutical Group had annual revenue of 12.02B CNY with 1.76% growth. Livzon Pharmaceutical Group had revenue of 2.90B in the quarter ending December 31, 2025, with 6.36% growth.
Revenue
12.02B
Revenue Growth
+1.76%
P/S Ratio
2.31
Revenue / Employee
1.35M
Employees
8,878
Market Cap
27.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.02B | 208.01M | 1.76% |
| Dec 31, 2024 | 11.81B | -617.70M | -4.97% |
| Dec 31, 2023 | 12.43B | -199.54M | -1.58% |
| Dec 31, 2022 | 12.63B | 565.72M | 4.69% |
| Jan 1, 2022 | 12.06B | 1.54B | 14.67% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Humanwell Healthcare (Group) | 23.96B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Dong-E-E-Jiao | 6.70B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.02B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Kangmei Pharmaceutical | 5.28B |